Ukuhlolwa kwe-HCV HBSAG kanye ne-Syphilish Rapid Combo Test
ULWAZI LOKUKHIQIZWA
| Inombolo Yemodeli | I-HBsAg/TP kanye ne-HIV/HCV | Ukupakisha | Izivivinyo ezingu-20/ikhithi, amakhithi angu-30/i-CTN |
| Igama | Ukuhlolwa Okusheshayo Kwe-HBsAg/TP kanye ne-HIV/HCV | Ukuhlukaniswa kwezinsimbi | Isigaba III |
| Izici | Ukuzwela okuphezulu, Ukusebenza okulula | Isitifiketi | I-CE/ ISO13485 |
| Ukunemba | > 97% | Isikhathi sokuphelelwa yisikhathi | Iminyaka Emibili |
| Indlela Yokwenza | Igolide le-Colloidal | Isevisi ye-OEM/ODM | Kuyatholakala |
Ukuphakama
Isikhathi sokuhlola: 15-20mins
Isitoreji: 2-30℃/36-86℉
Indlela: Igolide le-Colloidal
Isici:
• Ukuzwela okuphezulu
• ukufundwa kwemiphumela ngemizuzu eyi-15-20
• Ukusebenza okulula
• Ukunemba Okuphezulu
UKUSETSHENZISWA OKUHLOSIWE
Le khithi ifanelekela ukunqunywa kwekhwalithi ye-hepatitis B, i-syphilis spirochete, i-human immunodeficiency virus, kanye ne-hepatitis C virus ku-serum/plasma yomuntu.amasampula egazi aphelele/aphelele ukuze kutholakale ukuxilongwa okusizayo kwegciwane le-hepatitis B, i-syphilis spirochete, igciwane le-human immunodeficiency, kanye nokutheleleka kwegciwane le-hepatitis C. Imiphumela etholakele kufanelekufanele ihlaziywe kanye nolunye ulwazi lwezokwelapha. Yenzelwe ukusetshenziswa ochwepheshe bezokwelapha kuphela.
Inqubo yokuhlola
| 1 | Funda imiyalelo yokusebenzisa futhi uhambisane ngokuqinile nemiyalelo yokusebenzisa okudingekayo ukuze ugweme ukuthinta ukunemba kwemiphumela yokuhlolwa. |
| 2 | Ngaphambi kokuhlolwa, ikhithi kanye nesampula kukhishwa esimweni sokugcina bese kulinganiswa nokushisa kwegumbi bese kuphawulwa. |
| 3 | Udabula iphakethe lesikhwama se-aluminium foil, khipha idivayisi yokuhlola bese uyimaka, bese uyibeka ngokuvundlile etafuleni lokuhlola. |
| 4 | Faka amasampula e-serum/plasma nge-dropper elahlwayo bese ufaka amaconsi amabili emgodini ngamunye we-s1 kanye ne-s2; engeza amaconsi amathathu emgodini ngamunye we-s1 kanye ne-s2 kumasampula egazi lonke ngaphambi kokufaka amaconsi angu-1 ~ 2 esisombululo sokuhlanza emgodini ngamunye we-s1 kanye ne-s2 bese isikhathi sesiqalile. |
| 5 | Imiphumela yokuhlolwa kufanele ihunyushwe zingakapheli imizuzu eyi-15-20, uma imiphumela ehunyushwe engaphezu kwemizuzu engama-20 ingavumelekile. |
| 6 | Ukuhumusha okubonakalayo kungasetshenziswa ekuchazeni imiphumela. |
Qaphela: isampula ngayinye kufanele ifakwe ngepayipi elihlanzekile elilahlwayo ukuze kugwenywe ukungcola okuxubile.
UKUSEBENZA KWEMITHOLAMPILO
| Imiphumela ye-WIZ yeI-HBsag
| Umphumela wokuhlolwa kwe-reagent ebhekiselayo | Izinga elihle lokuhlangana kwezinto: 99.06% （95%CI 96.64%~99.74%） Izinga lokuhlangana okungalungile: 98.69% （95%CI96.68%~99.49%） Izinga lokuhlangana kwento yonke: 98.84% (95%CI97.50%~99.47% | ||
| Okuhle | Okubi | Isiyonke | ||
| Okuhle | 211 | 4 | 215 | |
| Okubi | 2 | 301 | 303 | |
| Isiyonke | 213 | 305 | 518 | |
| Imiphumela ye-WIZ yeTP
| Umphumela wokuhlolwa kwe-reagent ebhekiselayo | Izinga elihle lokuhlangana kwezinto: 96.18% （95%CI 91.38%~98.36%） Izinga lokuhlangana okungalungile: 97.67% （95%CI95.64%~98.77%） Izinga lokuhlangana kwento yonke: 97.30% （95%CI95.51%~98.38%） | ||
| Okuhle | Okubi | Isiyonke | ||
| Okuhle | 126 | 9 | 135 | |
| Okubi | 5 | 378 | 383 | |
| Isiyonke | 131 | 387 | 518 | |
| Imiphumela ye-WIZ yeI-HCV
| Umphumela wokuhlolwa kwe-reagent ebhekiselayo | Izinga elihle lokuhlangana kwezinto: 93.44% （95%CI 84.32%~97.42%） Izinga lokuhlangana okungalungile: 99.56% （95%CI98.42%~99.88%） Izinga lokuhlangana kwento yonke: 98.84% （95%CI97.50%~99.47%） | ||
| Okuhle | Okubi | Isiyonke | ||
| Okuhle | 57 | 2 | 59 | |
| Okubi | 4 | 455 | 459 | |
| Isiyonke | 61 | 457 | 518 | |
| Imiphumela ye-WIZ yeI-HIV
| Umphumela wokuhlolwa kwe-reagent ebhekiselayo | Izinga elihle lokuhlangana kwezinto: 96.81% （95%CI 91.03%~98.91%） Izinga lokuhlangana okungalungile: 99.76% （95%CI98.68%~99.96%） Izinga lokuhlangana kwento yonke: 99.23% （95%CI98.03%~99.70%） | ||
| Okuhle | Okubi | Isiyonke | ||
| Okuhle | 91 | 1 | 92 | |
| Okubi | 3 | 423 | 446 | |
| Isiyonke | 94 | 424 | 518 | |
